Please Wait...

Bioclinica Launches Clean Patient Optics to Accelerate Database Lock and Clinical Trial Timelines

Empowers sponsors and CROs with insights on study health

June 16, 2017

Bioclinica® eHealth Solutions, which provides an agile ecosystem and domain expertise for sponsors and CROs to speed clinical development, announces the launch of Clean Patient Optics™, a first-of-its kind, fully-validated clinical trial software solution that surfaces insights to patient data for accelerated database lock and clinical trial timelines. The innovative product provides uninterrupted visibility into patient data status at the study, site and patient level, empowering study teams to optimally focus the data cleaning process and remove obstacles that can create costly delays.

Andrew Masters

"Achieving database lock on time can be difficult, especially in larger trials with a vast amount of data to review and reconcile," says Bioclinica's eHealth Solutions Chief Technical Officer Andrew Masters. Clean Patient Optics is a technology-enabled solution for faster, easier and more efficient data cleaning and reconciliation. "Users apply insights to focus data cleaning, allowing the study team to meet or beat the database lock goal by days or even weeks."

"Our seamless solution provides sponsors and CROs unmatched capability to understand study health for accelerated clinical trial timelines."

- Andrew Masters, Chief Technology Officer, eHealth Solutions, Bioclinica

Moreover, Clean Patient Optics serves as an early warning system, signaling if a vendor is behind on making updates, or if a site is slow in reporting SAE information to the pharmacovigilance team. With powerful data visualization tools at their fingertips, study teams can uncover patterns and observations about the status of patient data external to the EDC system, such as ECG, Central Safety Lab and other important data requiring reconciliation, helping avoid surprises at the end of a study.

The entire study team benefits from Clean Patient Optics. Executive level personnel get answers about overall study health and team progress toward the database lock goal. Study managers, data managers and monitors see at a glance if a patient has reached the end of the study and any remaining data activities. They can quickly spot missing information, items to be reconciled, terms to be medically coded and pages to be source document verified.

The benefits of implementing Clean Patient Optics for visibility into patient data cleaning include:

  • Better and faster identification of specific bottlenecks to take action quicker
  • Improved data cleaning resource allocation
  • Decreased time to database lock ─ and with fewer surprises
  • Lower costs through improved efficiencies

Clean Patient Optics is readily implemented as a companion product to Bioclinica's best-in-class Express® Electronic Data Capture (EDC) system and Data Management services ─ the enterprise solution of choice for world-leading pharmaceutical companies and CROs.

"Our seamless solution provides sponsors and CROs unmatched capability to understand study health for accelerated clinical trial timelines," Masters comments. Clean Patient Optics is another example of how Bioclinica continues to invest and innovate. "We're pleased to deliver solutions in more areas of clinical development than any other technology provider, enabling organizations to see more clearly in their clinical research ─ and where it makes a real difference."

Deployment is fast and easy on all new studies where Bioclinica's Express EDC and Data Management solution are in use, requiring little time and effort to learn and use effectively. "All studies, no matter the size or therapeutic area, can benefit from Clean Patient Optics," Masters adds.

Learn more online about Clean Patient Optics and Bioclinica Express, and read the Bioclinica blog and latest news on Bioclinica LinkedIn and Twitter channels.

About Bioclinica

Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval.  The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development.  The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen